- 期刊
滾動調整2025年C肝消除治療目標數
Towards HCV elimination by 2025: rolling update of the estimated number of persons with chronic HCV infection
參考文獻
WHO. Global Health Sector Strategy on Viral Hepatitis 2016-2021: Towards Ending Viral Hepatitis (WHO/HIV/2016.06). Geneva: WHO, 2016.
國家消除C肝政策綱領編輯團隊：國家消除C肝政策綱領2018-2025。台北：衛生福利部，2019。 Taiwan National Hepatitis C Program Office, Ministry of Health and Welfare, R.O.C. (Taiwan). Taiwan Hepatitis C Policy Guideline 2018-2025. Taipei: Ministry of Health and Welfare, R.O.C. (Taiwan), 2019. [In Chinese]
衛生福利部國民健康署：為配合國家消除C肝政策，自109年9月28日起調整成人預防保健服務B、C型肝炎篩檢年齡為45歲至79歲終身一次(衛授國字第1090600765號)。https://www.hpa.gov.tw。引用2022/12/18。 Health Promotion Administration, Ministry of Health and Welfare, R.O.C. (Taiwan). To cooperate with the national policy of eliminating liver C, the adult preventive care service related to hepatitis B and C screening was adjusted to once in life from 45 to 79 years old from September 28, 2010 (Wei Shou Guo Zi No. 1090600765). Available at: https://www.hpa.gov.tw. Accessed December 18, 2022. [In Chinese]
衛生福利部國家消除C肝辦公室：消除C肝進度監測平台。https://www.mohw.gov.tw/dl-77667-ed4abe35-39b9-4f7b-ab44-8683becefb11.html。引用2022/12/18。 Taiwan National Hepatitis C Program Office, Ministry of Health and Welfare, R.O.C. (Taiwan). Taiwan National Hepatitis C Elimination Progress Monitoring Information Network. Available at: https://www.mohw.gov.tw/dl-77667-ed4abe35-39b9-4f7b-ab44-8683becefb11.html. Accessed December 18, 2022. [In Chinese]
WHO. Interim Guidance for Country Validation of Viral Hepatitis Elimination (Licence: CC BY-NC-SA 3.0 IGO). Geneva: WHO, 2021.
被引用紀錄
楊雯雯、吳慧敏、劉嘉玲、鄭國本、余明隆、蒲若芳、盧勝男、簡榮南（2023）。C型肝炎病毒抗體快篩試劑的運用。台灣公共衛生雜誌，42(6)，594-611。https://doi.org/10.6288/TJPH.202312_42(6).112031
楊雯雯、劉嘉玲、吳慧敏、鄭國本、盧勝男、簡榮南、蒲若芳（2023）。推動消除C肝政策之回顧。台灣公共衛生雜誌，42(2)，165-179。https://doi.org/10.6288/TJPH.202304_42(2).112006
延伸閱讀
- Hshiao, M. H., Chen, T. B., Du, W. C., Hsu, S. Y., Ou, H. Y., Huang, Y. H., Chan, S. H., Lee, C. C., & Lu, N. H. (2021). 探討以最佳化擴張加權影像b值來正確偵測與評估肝細胞腫瘤大小. 中華放射線技術學雜誌, 45(3), 159-166. https://www.airitilibrary.com/Article/Detail?DocID=16849418-202109-202112160007-202112160007-159-166
- 史麗珠、林昌明、陳佳伶、陳全美、蔡麗紅（2012）。肝硬化自我照顧知識行為：量表設計及信效度評估。秀傳醫學雜誌，11(1&2)，1-10。https://www.airitilibrary.com/Article/Detail?DocID=15610497-201206-201309090005-201309090005-1-10
- 楊雯雯、劉嘉玲、吳慧敏、鄭國本、盧勝男、簡榮南、蒲若芳（2023）。推動消除C肝政策之回顧。台灣公共衛生雜誌，42(2)，165-179。https://doi.org/10.6288/TJPH.202304_42(2).112006
- Meng, X., Yang, D., Yu, R., & Zhu, H. (2015). EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection. Mediators of Inflammation, 2015(), 710-722-373. https://doi.org/10.1155/2015/716315
- 胡宗錡（2012）。Relative Quantification of Potential Biomarkers of HCV-related Diseases by LC-MS/MS〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2012.01434